Nannan Liu

机构：Harbin Medical University, Beijing University of Chinese Medicine, Weinan Normal University, Anshan Normal University, Fourth Affiliated Hospital of Harbin Medical University, Command Hospital · ORCID：0000-0002-9324-376X

发表论文 68 篇 · 总被引 976 次 · h-index 19

代表论文

• Effect of in vitro digestion and fermentation of kiwifruit pomace polysaccharides on structural characteristics and human gut microbiota (2023 · International Journal of Biological Macromolecules · 被引 45)
• Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease (2022 · International Journal of Molecular Sciences · 被引 44)
• Effects of Auricularia auricula Polysaccharides on Gut Microbiota Composition in Type 2 Diabetic Mice (2022 · Molecules · 被引 33)
• Recent advances of tanshinone in regulating autophagy for medicinal research (2023 · Frontiers in Pharmacology · 被引 29)
• LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53 ‐driven tumour progression through miR‐5683/FGF2 (2024 · Clinical and Translational Medicine · 被引 24)
• Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway (2022 · Biomedicine & Pharmacotherapy · 被引 23)